Table 2. Serum and retina malondialdehyde (MDA) levels and reduced glutathione (GSH), catalase, and superoxide dismutase (SOD) activity (p* value, all groups vs. control; p** value, treated vs. untreated) in retinas of different groups (mean±S.D.).
| Groups | Serum MDA µmol/L | Retina | |||
|---|---|---|---|---|---|
| MDA µmol/mg protein | GSH µg/mg protein | Catalase U/mg protein | SOD U/mg protein | ||
| Group I (n=15) | |||||
| Range | 24–15.6 | 98–196 | 104–546 | 992–2349 | 956–2623 |
| Mean±S.D. | 75±12 | 66.7±28 | 284±52 | 1249±140 | 1545±191 |
| Group IIa (n=12) | |||||
| Range | 40–89 | 190–261 | 68.7–221.5 | 109.5–642 | 453–1342 |
| Mean±S.E. | 48±5.9 | 188±37 | 123.6±19.3 | 358±65 | 760±78 |
| p* value | <0.01 | N.S. | <0.01 | <0.001 | <0.001 |
| Group IIb (n=13) | |||||
| Range | 33–56 | 149–213 | 121–496 | 706–2002 | 876–1987 |
| Mean±S.E. | 31±12.2 | 142±32 | 259±50 | 843±134 | 1021±1 |
| p* value | <0.01 | <0.001 | <0.001 | <0.001 | <0.001 |
| Group IIc (n=13) | |||||
| Range | 16–73.4 | 136–261 | 69.6–213.9 | 456–1632 | 962–1316 |
| Mean±S.E. | 33±2.7 | 133±25 | 128±16.4 | 987±56 | 836±53 |
| p** value | <0.001 | <0.001 | <0.05 | <0.001 | <0.001 |
| Group IId (n=14) | |||||
| Range | 22–73.4 | 156–261 | 69.6–213.9 | 546–1756 | 624–2116 |
| Mean±S.E. | 38±6.7 | 121±25 | 128±16.4 | 1112±86 | 1233±153 |
| p** value | <0.001 | N.S. | <0.05 | <0.001 | <0.001 |